Last reviewed · How we verify

NCT04940156: ID-AF

Comparison of the Performance of ICM and CIED in Detecting AF

Terminated NA Results posted Last updated 15 October 2024
What this trial tests

NA trial testing Confirm Rx (Implantable Cardiac Monitor) in Atrial Fibrillation in 6 participants. Terminated before completion.

Timeline
4 October 2021
Primary endpoint
23 November 2023
23 November 2023

Quick facts

Lead sponsorOxford University Hospitals NHS Trust
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment6
Start date4 October 2021
Primary completion23 November 2023
Estimated completion23 November 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Oxford University Hospitals NHS Trust

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this project is to study the performance of the two most commonly used Implantable Cardiac Monitors in detecting AF episodes and explore how the new connectivity can empower patients and improve patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Oxford University Hospitals NHS Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04940156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing